Synthesis of Super Potent Antibiotic Cystobactamide 861-2

Slides:



Advertisements
Similar presentations
ANTIBIOTIC By:Afnan Bakhsh. Sir Alexander Fleming (1881 –1955)  “One sometimes finds what one is not  looking for“ Penicillin He observed inhibition.
Advertisements

1 Chapter 9 Drugs for Bacterial, Viral, and Fungal Infections.
Younas Masih RN, Post RN BSc.N (Lecturer ) New Life College Of Nursing Karachi 11/7/20141Antimicrobial medications.
Toxicity of selenocyanate on the metalloid-resistant bacterium LHVE Rebecca A. Montes & Thomas G. Chasteen.
DEVELOPMENT IN THE PRODUCTION AND EFFECTIVENESS OF ARTEMISININ Background Information Currently, there is an epidemic of malaria in third world countries,
Susceptibility of Antibacterial Chemicals on Pseudomonas aeruginosa Research performed by: Clayton Brady Health Science Biology Major Tennessee Technological.
The Constructions of Stable Nucleic Nanostructures Anna Feng, Tamika Roberts Dr. James Canary Johan Guillaume NYU Department of Chemistry.
Novel Dihydrofolate Reductase Inhibitors. Structure- Based versus Diversity-Based Design and High- Throughput Synthesis and Screening Pierre C. Wyss, Paul.
TBA-354: TBA-354 is a promising new antituberculosis nitroimidazole derivative that was tested for pharmacokinetic profile and activity against M. tuberculosis.
Mouthwash Effectiveness in Eliminating Bacteria By: Matthew Mancuso Department of Biology Tennessee Technological University, Cookeville, TN
OMPI, Aprli 2005Athelas SA Copyright STARTUPS, IP AND ALL THAT SORT OF THINGS IP issues as seen from the limited perspective of a startup company active.
Lessons Learned from Organic Synthesis Joshua J. Nyman Howard Hughes Medical Institute Summer Scholar Research Project Mentor: Dr. Yan Zhang, Department.
Department of Chemistry Seminar Announcement Date/Time/VenueTitle/Speaker 21 Feb (Mon) 4pm – S8 Level 3 Executive Classroom Natural products and.
USE OF DRUGS AGAINST MICRO-ORGANISMS
ANTI-MICROBIALS – MEDICINAL CHEMISTRY Timothy Curd - Sunderland University - Supervised by Mark Ashton and Dr Yu Gong. Special acknowledgement to the Nuffield.
Immune System & Disease
Frequency of Antibiotic Resistance among Bacteria Isolated From a High School Setting Katie Amato Columbia High School.
MethodsAbstract Methods Results Printed by Novel 8-Heterocyle Substituted Tetracyclines are Potent and Broad Spectrum Antibacterial Agents with Oral Bioavailability.
Study the effect of industrial antibiotics on microbial growth.
Characterization of 3-OHFT 3-hydroxyflavothione was characterized by 1 H NMR, UV-Visible spectroscopy, LCMS and HPLC. This synthetic approach has resulted.
Combinatorial Chemistry Advanced Medicinal Chemistry (Pharm 5219): Section A Ref.: An Introduction to Medicinal Chemistry, 3 rd ed. 2005, G.L.Patrick,
Marine Biotechnology Introduction Sadia Tahir.  The most recent definition considers marine (or blue) biotechnology as "exploration of the capabilities.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Technologies + Future Outlook Microbiology. Since we have started to harness the amazing power of bacteria, the field of microbiology has become much.
Background First synthesized in 1908 Used primarily for Streptococcal species Domagk received Nobel Prize for derivatives in 1940 Large influx of derivatives.
Antibiotics By Dr. Humodi A. Saeed Associate Prof. of Medical Microbiology College of Medical Lab. Science Sudan University of Science and Technology E.
Lacie Smith April 22, 2005 Department of Chemistry and Biochemistry Can we fix it! Yes we can! Synthesis of Novel Quorum Sensing molecules.
Department of Pharmaceutical Chemistry, College of Pharmacy, Salman binabdulaziz University, Al-Kharj, Saudi Arabia  Quanazolines, a nitrogenous hetrocycles,
Synthesis of Garner’s Aldehyde Carmen Cannon, Kristina Truitt, Rachel Andrews, Bette’ Ford and Victoria Geisler Department of Chemistry, University of.
Bacteria: Beneficial, Infectious and Antibiotics
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Synthesis β-Aminophosphonates Speaker : Xuerui Wang Advisor : Jun Zhu 1.
O In Scheme 1, the first 4 steps have been carried out, resulting in the synthesis of Structure 4. o So far, high percent yields suggest that Scheme 1.
Antibiotic Resistance By Willy. What is Antibiotic Resistance? Antibiotic Resistance is a microorganism that is able to withstand the effects of antibiotics.
antibiotic sensitivity test, a laboratory method for determining the susceptibility of organisms to therapy with antibiotics. After the infecting organism.
Principles of Chemical Recognition and Transport in Extractive Separations: Synthesis of Dibenzo-14-Crown-4 Ethers Bearing Fluoroalcohol Lariats Peter.
Unit 3 Seminar Microbiology.
Professor Stephen Pyne School of Chemistry, University of Wollongong, New South Wales 2522, Australia  Research within the Pyne group.
Biotechnology Made up of 3 technologies: Bioprocess technology: when microorganisms are provided with nutrients and advantageous conditions, they perform.
Use of Metallic Antibacterial Coating in Glaucoma Treatment Device
Bacterial & Viral Infections
Section 3: Bacteria, Viruses, and Humans
Industrial Microorganisms and Product Formation
Environmental Impact of Some Medications
Synthesis, Characterization, and Computational Modeling of [Co(acacen)L2]+, an Inhibitor of Zinc Finger Proteins Thomas Williams, Matthew Currier, Timothy.
Sean Pierre-Louis, Marc Boudreau, Bill Butler
The New Penicillin?: Antimicrobial Effects of Puupehenone on Clostridium Difficile Nikki Huynh, Dr. William T. Self Ph.D. Department of Molecular Biology.
Today’s Drug Discovery Process “How Do We Discover Drugs”
University of New Hampshire, Department of Chemistry
An Introduction to Metabolism
Marine Biotechnology Introduction
Antimicrobial Susceptibility Testing (AST)
Development of New Arsenic Based Amidation Catalysts
1. Abstract 3. Objective of the study 4. Methods 5. Results
Department of Chemistry
Introduction to Lab Ex. 14: Antibiotic Sensitivity
Natural Selection & Biological Resistance
Chemotherapeutic agent
Introduction In addition to general-purpose media, which allow the growth of most types of bacteria, microbiologists use specialized media to identify.
Introduction to Bacteriology
Drug Resistance Bacteria are considered resistant to an antibiotic if the maximal level of that antibiotic that can be tolerated by the host does not halt.
QUICK REVIEW QUESTIONS:
Antibacterial Lab Biology - LHS.
1 2 Health Warning – Just one reason why you must support the New Florida Science Standards It has been all too easy to forget just how awful.
Antimicrobial Agents.
Combinatorial Chemistry
Antibacterial Drug Discovery (ADD) at Leeds
API 20 E System & Antibiotic susceptibility test
Introduction In addition to general-purpose media, which allow the growth of most types of bacteria, microbiologists use specialized media to identify.
Presentation transcript:

Synthesis of Super Potent Antibiotic Cystobactamide 861-2 Alison Deyett , Therese Planke, and Andreas Kirsching Department of Organic Chemistry, Leibniz University , Hannover, Germany Abstract Synthesis NMR The need for new potent antibiotics to fight both gram negative and gram positive bacteria is overwhelmingly extant in today’s society. Cystobactamides may hold the key to filling this void in medical resources, but they cannot be isolated in any amount to even test their validity. In order to combat this issue the complete synthesis of cystobactamide 861-2 has been developed and optimized to make this special compound in high enough yields for testing. Background Bacterial infections have become more prominent because bacteria have gained resistances to antibiotics already on the market 2 million people are infected by antibiotic resistance each year in the United States 23,000 people are killed from these infections each year The production of antibiotics can not keep up with the demand of resistant bacteria Cystobactemides Have shown promising results to get rid of many nosocomial infections that currently are very difficult to get rid of Are potent bactericidal agents that inhibit several Gram-negative and Gram-positive bacteria Are produced by Cystobacter sp. in very small amounts Can not be isolated from the other similar compounds through the fermentation process Must be organically synthesized Summary There is a need for new antibiotics that have the ability to fight new antibiotic resistant strains. The optimization of the addition of the azide has increased the possible yield to provide less waste and increase the production time of the desired cystobactamide. A large amount of the middle fragment of cystobactemide 861-2 was produced to be used for the completion of the rest of the compound. Optimization Future work The compound will be fully synthesize and tested for usefulness in the field Other cystobactamides will be synthesized and tested for usefulness This is the original work up that severely hindered the ability to make large amounts of the compound. Was first tried to change the work up of this product but it did not lead to a significant change in yield. References The product of this reaction was compound 4 but the alcohol group is protected by TMS and another side reaction in a 2:1 solution. 1. Moreno, M.; Elgaher, W.A; Herrmann, J.; Schlager, N.; Hamed, M.; Baumann, S.; Muller, R.; Hartman, R.W.; Kirschning, A. Synthesis and Biological Evaluation of Cystobactamid 507: A Bacterial Topoisomerase Inhibitor from Cystobacter sp. Synlett 2015, 26,1175-1178. 2. Baumann, S.; Hermann, J.; Raju, R.; Steinetz, H.; Mohr, K.; Huttel, S.; Harmrols, K; Stadler, M.; Muller, R. Cystobactamides: Myxobacterial Topoisomerase Inhibitiors Exhibiting Potent Antibacterial Activity. Angew. Chem. It Ed. 2014, 53, 14605-14609. Objective To generate 1 g of the middle fragment of Cystobactamide 861-2 in order to make a enough material for proper testing of the material Was first done in THF, but this resulted in two inseparable compounds mixed 2:1. DMF was used to promote the desired SN2 product Acknowledgement Work for this project was supported by the American Chemical Society’s International Research Experience for Undergraduates (IREU) program which is funded by the U.S. National Science Foundation under IIA-1261104. I would also like to thank Professor Andreas Kirschning for the opportunity to work in his lab and the guidance he provided.